BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 25370770)

  • 21. Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes.
    Kratz CP; Franke L; Peters H; Kohlschmidt N; Kazmierczak B; Finckh U; Bier A; Eichhorn B; Blank C; Kraus C; Kohlhase J; Pauli S; Wildhardt G; Kutsche K; Auber B; Christmann A; Bachmann N; Mitter D; Cremer FW; Mayer K; Daumer-Haas C; Nevinny-Stickel-Hinzpeter C; Oeffner F; Schlüter G; Gencik M; Überlacker B; Lissewski C; Schanze I; Greene MH; Spix C; Zenker M
    Br J Cancer; 2015 Apr; 112(8):1392-7. PubMed ID: 25742478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The perinatal presentation of cardiofaciocutaneous syndrome.
    Wong Ramsey KN; Loichinger MH; Slavin TP; Kuo S; Seaver LH
    Am J Med Genet A; 2014 Aug; 164A(8):2036-42. PubMed ID: 24719372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical manifestations in patients with SOS1 mutations range from Noonan syndrome to CFC syndrome.
    Narumi Y; Aoki Y; Niihori T; Sakurai M; Cavé H; Verloes A; Nishio K; Ohashi H; Kurosawa K; Okamoto N; Kawame H; Mizuno S; Kondoh T; Addor MC; Coeslier-Dieux A; Vincent-Delorme C; Tabayashi K; Aoki M; Kobayashi T; Guliyeva A; Kure S; Matsubara Y
    J Hum Genet; 2008; 53(9):834-841. PubMed ID: 18651097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of germline mutations in the Ras/MAPK signaling pathway on adaptive behavior: cardiofaciocutaneous syndrome and Noonan syndrome.
    Pierpont EI; Pierpont ME; Mendelsohn NJ; Roberts AE; Tworog-Dube E; Rauen KA; Seidenberg MS
    Am J Med Genet A; 2010 Mar; 152A(3):591-600. PubMed ID: 20186801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
    Lee ST; Ki CS; Lee HJ
    Clin Genet; 2007 Aug; 72(2):150-5. PubMed ID: 17661820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes.
    Kratz CP; Rapisuwon S; Reed H; Hasle H; Rosenberg PS
    Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):83-9. PubMed ID: 21500339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NRAS associated RASopathy and embryonal rhabdomyosarcoma.
    Garren B; Stephan M; Hogue JS
    Am J Med Genet A; 2020 Jan; 182(1):195-200. PubMed ID: 31697451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noonan and cardio-facio-cutaneous syndromes: two clinically and genetically overlapping disorders.
    Nyström AM; Ekvall S; Berglund E; Björkqvist M; Braathen G; Duchen K; Enell H; Holmberg E; Holmlund U; Olsson-Engman M; Annerén G; Bondeson ML
    J Med Genet; 2008 Aug; 45(8):500-6. PubMed ID: 18456719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CNS imaging is a key diagnostic tool in the evaluation of patients with CFC syndrome: two cases and literature review.
    Papadopoulou E; Sifakis S; Sol-Church K; Klein-Zighelboim E; Stabley DL; Raissaki M; Gripp KW; Kalmanti M
    Am J Med Genet A; 2011 Mar; 155A(3):605-11. PubMed ID: 21337689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.
    Leung GKC; Luk HM; Tang VHM; Gao WW; Mak CCY; Yu MHC; Wong WL; Chu YWY; Yang WL; Wong WHS; Ma ACH; Leung AYH; Jin DY; Chan KYK; Allanson J; Lo IFM; Chung BHY
    Sci Rep; 2018 Feb; 8(1):2421. PubMed ID: 29402968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Mutations Associated with Rasopathies in a Central European Population and Genotype-Phenotype Correlations.
    Čizmárová M; Hlinková K; Bertok S; Kotnik P; Duba HC; Bertalan R; Poločková K; Košťálová Ľ; Pribilincová Z; Hlavatá A; Kovács L; Ilenčíková D
    Ann Hum Genet; 2016 Jan; 80(1):50-62. PubMed ID: 26607044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of mutations in Noonan syndrome and their correlation with phenotypes.
    Lee BH; Kim JM; Jin HY; Kim GH; Choi JH; Yoo HW
    J Pediatr; 2011 Dec; 159(6):1029-35. PubMed ID: 21784453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive genetic analysis of overlapping syndromes of RAS/RAF/MEK/ERK pathway.
    Tumurkhuu M; Saitoh M; Sato A; Takahashi K; Mimaki M; Takita J; Takeshita K; Hama T; Oka A; Mizuguchi M
    Pediatr Int; 2010 Aug; 52(4):557-62. PubMed ID: 20030748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autism traits in the RASopathies.
    Adviento B; Corbin IL; Widjaja F; Desachy G; Enrique N; Rosser T; Risi S; Marco EJ; Hendren RL; Bearden CE; Rauen KA; Weiss LA
    J Med Genet; 2014 Jan; 51(1):10-20. PubMed ID: 24101678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autism spectrum disorder and other neurobehavioural comorbidities in rare disorders of the Ras/MAPK pathway.
    Garg S; Brooks A; Burns A; Burkitt-Wright E; Kerr B; Huson S; Emsley R; Green J
    Dev Med Child Neurol; 2017 May; 59(5):544-549. PubMed ID: 28160302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rasopathies - dysmorphic syndromes with short stature and risk of malignancy.
    Cizmarova M; Kostalova L; Pribilincova Z; Lasabova Z; Hlavata A; Kovacs L; Ilencikova D
    Endocr Regul; 2013 Oct; 47(4):217-22. PubMed ID: 24156711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines.
    Pierpont ME; Magoulas PL; Adi S; Kavamura MI; Neri G; Noonan J; Pierpont EI; Reinker K; Roberts AE; Shankar S; Sullivan J; Wolford M; Conger B; Santa Cruz M; Rauen KA
    Pediatrics; 2014 Oct; 134(4):e1149-62. PubMed ID: 25180280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuro-cardio-facial-cutaneous syndrome].
    Bessis D
    Ann Dermatol Venereol; 2011; 138(6-7):483-93. PubMed ID: 21700069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral profile in RASopathies.
    Alfieri P; Piccini G; Caciolo C; Perrino F; Gambardella ML; Mallardi M; Cesarini L; Leoni C; Leone D; Fossati C; Selicorni A; Digilio MC; Tartaglia M; Mercuri E; Zampino G; Vicari S
    Am J Med Genet A; 2014 Apr; 164A(4):934-42. PubMed ID: 24458522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two novel germline KRAS mutations: expanding the molecular and clinical phenotype.
    Stark Z; Gillessen-Kaesbach G; Ryan MM; Cirstea IC; Gremer L; Ahmadian MR; Savarirayan R; Zenker M
    Clin Genet; 2012 Jun; 81(6):590-4. PubMed ID: 21797849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.